FindTrial
Sign In

Pharmacogenomincs study of platinum resistance in ovarian cancer

Pharmacogenomincs study of platinum resistance in ovarian cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15007604
Enrollment
Unknown
Registered
2015-12-10
Start date
2005-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Case series:Nil

Sponsors

Institute of Clinical Pharmacology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: female; >=18 years old epithelial ovarian cancer patient; patients treated with maximal cytoreductive surgery followed by adjuvant platinum chemotherapy; All patients provided written informed consent prior to participation in the study.

Exclusion criteria

Exclusion criteria: Other pathological tissue types of ovarian cancer patients;Patients with other tumors;Pregnant women and nursing

Design outcomes

Primary

MeasureTime frame
genotype;—

Contacts

Public ContactYingzi Liu
yzliu2005@163.com+86 13574860731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026